Infliximab and biosimilar infliximab in psoriasis: efficacy, loss of efficacy, and adverse events
Smriti Subedi,1,2,* Yu Gong,1,2,* Youdong Chen,1,2, Yuling Shi1,21Department of Dermatology, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai 200072, People’s Republic of China; 2Department of Dermatology, Institute of Psoriasis, Tongji University...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2019-07-01
|
| Series: | Drug Design, Development and Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/infliximab-and-biosimilar-infliximab-in-psoriasis-efficacy-loss-of-eff-peer-reviewed-article-DDDT |